aluates Reports

$ 0.0

Automative

Global Urinary Tract Infection (UTI) Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-28U5742

Global Urinary Tract Infection UTI Market Insights and Forecast to 2028

BUY CHAPTERS

Global Urinary Tract Infection (UTI) Market Research Report 2025

Code: QYRE-Auto-28U5742

Report

September 2025

Pages:101

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

GlaxoSmithKline PLC

Dr. Reddy’s Laboratories Ltd.

Pfizer Inc

Roche

Astrazeneca plc

Cipla Ltd

Johnson & Johnson

Bayer

Teva Pharmaceutical Industries

Boehringer Ingelheim

Sanofi

Lily

Abbott

JinShuiBao

Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

Sinopharm

Borui Medicine

Zhejiang Xianju Pharmaceutical

Sichuan Guorui Pharmaceutical

Hengrui Pharmaceutical

Johnson & Johnson

Urinary Tract Infection (UTI) Market

The global market for Urinary Tract Infection (UTI) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Urinary tract infection (UTI), is an infectious disease caused by the growth and proliferation of pathogens in the urinary tract.Pathogens may include bacteria, mycoplasma, chlamydia, viruses, etc.Urinary tract infection is the second most common infectious disease after respiratory tract infection.Shock deaths from urinary tract infections were the third leading cause of death.

North American market for Urinary Tract Infection (UTI) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Urinary Tract Infection (UTI) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Urinary Tract Infection (UTI) in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Urinary Tract Infection (UTI) include Novartis AG, GlaxoSmithKline, Dr. Reddy’s Laboratories Ltd.,, Pfizer, Roche, AstraZeneca,, Cipla, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Urinary Tract Infection (UTI), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urinary Tract Infection (UTI).

The Urinary Tract Infection (UTI) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Urinary Tract Infection (UTI) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Urinary Tract Infection (UTI) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Urinary Tract Infection (UTI) Market Report

Report Metric	Details
Report Name	Urinary Tract Infection (UTI) Market
Segment by Type	By Site of Infection By Clinical Symptoms By Presence of Urinary Tract Abnormalities
Segment by Application	Hospitals Clinic Self-administered Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis AG, GlaxoSmithKline, Dr. Reddy’s Laboratories Ltd.,, Pfizer, Roche, AstraZeneca,, Cipla, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries, Boehringer Ingelheim, Sanofi, Lily, Abbott, JinShuiBao, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding), Sinopharm, Borui Medicine, Zhejiang Xianju Pharmaceutical, Sichuan Guorui Pharmaceutical, Hengrui Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Urinary Tract Infection (UTI) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Urinary Tract Infection (UTI) Market report?

Ans: The main players in the Urinary Tract Infection (UTI) Market are Novartis AG, GlaxoSmithKline, Dr. Reddy’s Laboratories Ltd.,, Pfizer, Roche, AstraZeneca,, Cipla, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries, Boehringer Ingelheim, Sanofi, Lily, Abbott, JinShuiBao, Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding), Sinopharm, Borui Medicine, Zhejiang Xianju Pharmaceutical, Sichuan Guorui Pharmaceutical, Hengrui Pharmaceutical

What are the Application segmentation covered in the Urinary Tract Infection (UTI) Market report?

Ans: The Applications covered in the Urinary Tract Infection (UTI) Market report are Hospitals, Clinic, Self-administered, Others

What are the Type segmentation covered in the Urinary Tract Infection (UTI) Market report?

Ans: The Types covered in the Urinary Tract Infection (UTI) Market report are By Site of Infection, By Clinical Symptoms, By Presence of Urinary Tract Abnormalities

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Urinary Tract Infection (UTI) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 By Site of Infection

1.2.3 By Clinical Symptoms

1.2.4 By Presence of Urinary Tract Abnormalities

1.3 Market by Application

1.3.1 Global Urinary Tract Infection (UTI) Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Self-administered

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Urinary Tract Infection (UTI) Market Perspective (2020-2031)

2.2 Global Urinary Tract Infection (UTI) Growth Trends by Region

2.2.1 Global Urinary Tract Infection (UTI) Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Urinary Tract Infection (UTI) Historic Market Size by Region (2020-2025)

2.2.3 Urinary Tract Infection (UTI) Forecasted Market Size by Region (2026-2031)

2.3 Urinary Tract Infection (UTI) Market Dynamics

2.3.1 Urinary Tract Infection (UTI) Industry Trends

2.3.2 Urinary Tract Infection (UTI) Market Drivers

2.3.3 Urinary Tract Infection (UTI) Market Challenges

2.3.4 Urinary Tract Infection (UTI) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Urinary Tract Infection (UTI) Players by Revenue

3.1.1 Global Top Urinary Tract Infection (UTI) Players by Revenue (2020-2025)

3.1.2 Global Urinary Tract Infection (UTI) Revenue Market Share by Players (2020-2025)

3.2 Global Urinary Tract Infection (UTI) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Urinary Tract Infection (UTI) Revenue

3.4 Global Urinary Tract Infection (UTI) Market Concentration Ratio

3.4.1 Global Urinary Tract Infection (UTI) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Urinary Tract Infection (UTI) Revenue in 2024

3.5 Global Key Players of Urinary Tract Infection (UTI) Head office and Area Served

3.6 Global Key Players of Urinary Tract Infection (UTI), Product and Application

3.7 Global Key Players of Urinary Tract Infection (UTI), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Urinary Tract Infection (UTI) Breakdown Data by Type

4.1 Global Urinary Tract Infection (UTI) Historic Market Size by Type (2020-2025)

4.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Type (2026-2031)

5 Urinary Tract Infection (UTI) Breakdown Data by Application

5.1 Global Urinary Tract Infection (UTI) Historic Market Size by Application (2020-2025)

5.2 Global Urinary Tract Infection (UTI) Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Urinary Tract Infection (UTI) Market Size (2020-2031)

6.2 North America Urinary Tract Infection (UTI) Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Urinary Tract Infection (UTI) Market Size by Country (2020-2025)

6.4 North America Urinary Tract Infection (UTI) Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Urinary Tract Infection (UTI) Market Size (2020-2031)

7.2 Europe Urinary Tract Infection (UTI) Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Urinary Tract Infection (UTI) Market Size by Country (2020-2025)

7.4 Europe Urinary Tract Infection (UTI) Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Urinary Tract Infection (UTI) Market Size (2020-2031)

8.2 Asia-Pacific Urinary Tract Infection (UTI) Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2020-2025)

8.4 Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Urinary Tract Infection (UTI) Market Size (2020-2031)

9.2 Latin America Urinary Tract Infection (UTI) Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Urinary Tract Infection (UTI) Market Size by Country (2020-2025)

9.4 Latin America Urinary Tract Infection (UTI) Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Urinary Tract Infection (UTI) Market Size (2020-2031)

10.2 Middle East & Africa Urinary Tract Infection (UTI) Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2020-2025)

10.4 Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis AG

11.1.1 Novartis AG Company Details

11.1.2 Novartis AG Business Overview

11.1.3 Novartis AG Urinary Tract Infection (UTI) Introduction

11.1.4 Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.1.5 Novartis AG Recent Development

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Details

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Urinary Tract Infection (UTI) Introduction

11.2.4 GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.2.5 GlaxoSmithKline Recent Development

11.3 Dr. Reddy’s Laboratories Ltd.,

11.3.1 Dr. Reddy’s Laboratories Ltd., Company Details

11.3.2 Dr. Reddy’s Laboratories Ltd., Business Overview

11.3.3 Dr. Reddy’s Laboratories Ltd., Urinary Tract Infection (UTI) Introduction

11.3.4 Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.3.5 Dr. Reddy’s Laboratories Ltd., Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Urinary Tract Infection (UTI) Introduction

11.4.4 Pfizer Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Urinary Tract Infection (UTI) Introduction

11.5.4 Roche Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.5.5 Roche Recent Development

11.6 AstraZeneca,

11.6.1 AstraZeneca, Company Details

11.6.2 AstraZeneca, Business Overview

11.6.3 AstraZeneca, Urinary Tract Infection (UTI) Introduction

11.6.4 AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.6.5 AstraZeneca, Recent Development

11.7 Cipla

11.7.1 Cipla Company Details

11.7.2 Cipla Business Overview

11.7.3 Cipla Urinary Tract Infection (UTI) Introduction

11.7.4 Cipla Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.7.5 Cipla Recent Development

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Details

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Urinary Tract Infection (UTI) Introduction

11.8.4 Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.8.5 Johnson & Johnson Recent Development

11.9 Bayer AG

11.9.1 Bayer AG Company Details

11.9.2 Bayer AG Business Overview

11.9.3 Bayer AG Urinary Tract Infection (UTI) Introduction

11.9.4 Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.9.5 Bayer AG Recent Development

11.10 Teva Pharmaceutical Industries

11.10.1 Teva Pharmaceutical Industries Company Details

11.10.2 Teva Pharmaceutical Industries Business Overview

11.10.3 Teva Pharmaceutical Industries Urinary Tract Infection (UTI) Introduction

11.10.4 Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.10.5 Teva Pharmaceutical Industries Recent Development

11.11 Boehringer Ingelheim

11.11.1 Boehringer Ingelheim Company Details

11.11.2 Boehringer Ingelheim Business Overview

11.11.3 Boehringer Ingelheim Urinary Tract Infection (UTI) Introduction

11.11.4 Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.11.5 Boehringer Ingelheim Recent Development

11.12 Sanofi

11.12.1 Sanofi Company Details

11.12.2 Sanofi Business Overview

11.12.3 Sanofi Urinary Tract Infection (UTI) Introduction

11.12.4 Sanofi Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.12.5 Sanofi Recent Development

11.13 Lily

11.13.1 Lily Company Details

11.13.2 Lily Business Overview

11.13.3 Lily Urinary Tract Infection (UTI) Introduction

11.13.4 Lily Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.13.5 Lily Recent Development

11.14 Abbott

11.14.1 Abbott Company Details

11.14.2 Abbott Business Overview

11.14.3 Abbott Urinary Tract Infection (UTI) Introduction

11.14.4 Abbott Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.14.5 Abbott Recent Development

11.15 JinShuiBao

11.15.1 JinShuiBao Company Details

11.15.2 JinShuiBao Business Overview

11.15.3 JinShuiBao Urinary Tract Infection (UTI) Introduction

11.15.4 JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.15.5 JinShuiBao Recent Development

11.16 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

11.16.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details

11.16.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview

11.16.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Urinary Tract Infection (UTI) Introduction

11.16.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.16.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development

11.17 Sinopharm

11.17.1 Sinopharm Company Details

11.17.2 Sinopharm Business Overview

11.17.3 Sinopharm Urinary Tract Infection (UTI) Introduction

11.17.4 Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.17.5 Sinopharm Recent Development

11.18 Borui Medicine

11.18.1 Borui Medicine Company Details

11.18.2 Borui Medicine Business Overview

11.18.3 Borui Medicine Urinary Tract Infection (UTI) Introduction

11.18.4 Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.18.5 Borui Medicine Recent Development

11.19 Zhejiang Xianju Pharmaceutical

11.19.1 Zhejiang Xianju Pharmaceutical Company Details

11.19.2 Zhejiang Xianju Pharmaceutical Business Overview

11.19.3 Zhejiang Xianju Pharmaceutical Urinary Tract Infection (UTI) Introduction

11.19.4 Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.19.5 Zhejiang Xianju Pharmaceutical Recent Development

11.20 Sichuan Guorui Pharmaceutical

11.20.1 Sichuan Guorui Pharmaceutical Company Details

11.20.2 Sichuan Guorui Pharmaceutical Business Overview

11.20.3 Sichuan Guorui Pharmaceutical Urinary Tract Infection (UTI) Introduction

11.20.4 Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.20.5 Sichuan Guorui Pharmaceutical Recent Development

11.21 Hengrui Pharmaceutical

11.21.1 Hengrui Pharmaceutical Company Details

11.21.2 Hengrui Pharmaceutical Business Overview

11.21.3 Hengrui Pharmaceutical Urinary Tract Infection (UTI) Introduction

11.21.4 Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2020-2025)

11.21.5 Hengrui Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

GlaxoSmithKline PLC

Dr. Reddy’s Laboratories Ltd.

Pfizer Inc

Roche

Astrazeneca plc

Cipla Ltd

Johnson & Johnson

Bayer

Teva Pharmaceutical Industries

Boehringer Ingelheim

Sanofi

Lily

Abbott

JinShuiBao

Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)

Sinopharm

Borui Medicine

Zhejiang Xianju Pharmaceutical

Sichuan Guorui Pharmaceutical

Hengrui Pharmaceutical

Johnson & Johnson

List of Tables

Table 1. Global Urinary Tract Infection (UTI) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of By Site of Infection

Table 3. Key Players of By Clinical Symptoms

Table 4. Key Players of By Presence of Urinary Tract Abnormalities

Table 5. Global Urinary Tract Infection (UTI) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Urinary Tract Infection (UTI) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Urinary Tract Infection (UTI) Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Urinary Tract Infection (UTI) Market Share by Region (2020-2025)

Table 9. Global Urinary Tract Infection (UTI) Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Urinary Tract Infection (UTI) Market Share by Region (2026-2031)

Table 11. Urinary Tract Infection (UTI) Market Trends

Table 12. Urinary Tract Infection (UTI) Market Drivers

Table 13. Urinary Tract Infection (UTI) Market Challenges

Table 14. Urinary Tract Infection (UTI) Market Restraints

Table 15. Global Urinary Tract Infection (UTI) Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Urinary Tract Infection (UTI) Market Share by Players (2020-2025)

Table 17. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Tract Infection (UTI) as of 2024)

Table 18. Ranking of Global Top Urinary Tract Infection (UTI) Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Urinary Tract Infection (UTI) Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Urinary Tract Infection (UTI), Headquarters and Area Served

Table 21. Global Key Players of Urinary Tract Infection (UTI), Product and Application

Table 22. Global Key Players of Urinary Tract Infection (UTI), Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Urinary Tract Infection (UTI) Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2020-2025)

Table 26. Global Urinary Tract Infection (UTI) Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Urinary Tract Infection (UTI) Revenue Market Share by Type (2026-2031)

Table 28. Global Urinary Tract Infection (UTI) Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Urinary Tract Infection (UTI) Revenue Market Share by Application (2020-2025)

Table 30. Global Urinary Tract Infection (UTI) Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Urinary Tract Infection (UTI) Revenue Market Share by Application (2026-2031)

Table 32. North America Urinary Tract Infection (UTI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Urinary Tract Infection (UTI) Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Urinary Tract Infection (UTI) Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Urinary Tract Infection (UTI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Urinary Tract Infection (UTI) Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Urinary Tract Infection (UTI) Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Urinary Tract Infection (UTI) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Urinary Tract Infection (UTI) Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Urinary Tract Infection (UTI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Urinary Tract Infection (UTI) Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Urinary Tract Infection (UTI) Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Urinary Tract Infection (UTI) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Urinary Tract Infection (UTI) Market Size by Country (2026-2031) & (US$ Million)

Table 47. Novartis AG Company Details

Table 48. Novartis AG Business Overview

Table 49. Novartis AG Urinary Tract Infection (UTI) Product

Table 50. Novartis AG Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 51. Novartis AG Recent Development

Table 52. GlaxoSmithKline Company Details

Table 53. GlaxoSmithKline Business Overview

Table 54. GlaxoSmithKline Urinary Tract Infection (UTI) Product

Table 55. GlaxoSmithKline Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 56. GlaxoSmithKline Recent Development

Table 57. Dr. Reddy’s Laboratories Ltd., Company Details

Table 58. Dr. Reddy’s Laboratories Ltd., Business Overview

Table 59. Dr. Reddy’s Laboratories Ltd., Urinary Tract Infection (UTI) Product

Table 60. Dr. Reddy’s Laboratories Ltd., Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 61. Dr. Reddy’s Laboratories Ltd., Recent Development

Table 62. Pfizer Company Details

Table 63. Pfizer Business Overview

Table 64. Pfizer Urinary Tract Infection (UTI) Product

Table 65. Pfizer Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 66. Pfizer Recent Development

Table 67. Roche Company Details

Table 68. Roche Business Overview

Table 69. Roche Urinary Tract Infection (UTI) Product

Table 70. Roche Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 71. Roche Recent Development

Table 72. AstraZeneca, Company Details

Table 73. AstraZeneca, Business Overview

Table 74. AstraZeneca, Urinary Tract Infection (UTI) Product

Table 75. AstraZeneca, Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 76. AstraZeneca, Recent Development

Table 77. Cipla Company Details

Table 78. Cipla Business Overview

Table 79. Cipla Urinary Tract Infection (UTI) Product

Table 80. Cipla Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 81. Cipla Recent Development

Table 82. Johnson & Johnson Company Details

Table 83. Johnson & Johnson Business Overview

Table 84. Johnson & Johnson Urinary Tract Infection (UTI) Product

Table 85. Johnson & Johnson Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 86. Johnson & Johnson Recent Development

Table 87. Bayer AG Company Details

Table 88. Bayer AG Business Overview

Table 89. Bayer AG Urinary Tract Infection (UTI) Product

Table 90. Bayer AG Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 91. Bayer AG Recent Development

Table 92. Teva Pharmaceutical Industries Company Details

Table 93. Teva Pharmaceutical Industries Business Overview

Table 94. Teva Pharmaceutical Industries Urinary Tract Infection (UTI) Product

Table 95. Teva Pharmaceutical Industries Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 96. Teva Pharmaceutical Industries Recent Development

Table 97. Boehringer Ingelheim Company Details

Table 98. Boehringer Ingelheim Business Overview

Table 99. Boehringer Ingelheim Urinary Tract Infection (UTI) Product

Table 100. Boehringer Ingelheim Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 101. Boehringer Ingelheim Recent Development

Table 102. Sanofi Company Details

Table 103. Sanofi Business Overview

Table 104. Sanofi Urinary Tract Infection (UTI) Product

Table 105. Sanofi Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 106. Sanofi Recent Development

Table 107. Lily Company Details

Table 108. Lily Business Overview

Table 109. Lily Urinary Tract Infection (UTI) Product

Table 110. Lily Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 111. Lily Recent Development

Table 112. Abbott Company Details

Table 113. Abbott Business Overview

Table 114. Abbott Urinary Tract Infection (UTI) Product

Table 115. Abbott Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 116. Abbott Recent Development

Table 117. JinShuiBao Company Details

Table 118. JinShuiBao Business Overview

Table 119. JinShuiBao Urinary Tract Infection (UTI) Product

Table 120. JinShuiBao Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 121. JinShuiBao Recent Development

Table 122. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details

Table 123. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview

Table 124. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Urinary Tract Infection (UTI) Product

Table 125. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 126. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development

Table 127. Sinopharm Company Details

Table 128. Sinopharm Business Overview

Table 129. Sinopharm Urinary Tract Infection (UTI) Product

Table 130. Sinopharm Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 131. Sinopharm Recent Development

Table 132. Borui Medicine Company Details

Table 133. Borui Medicine Business Overview

Table 134. Borui Medicine Urinary Tract Infection (UTI) Product

Table 135. Borui Medicine Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 136. Borui Medicine Recent Development

Table 137. Zhejiang Xianju Pharmaceutical Company Details

Table 138. Zhejiang Xianju Pharmaceutical Business Overview

Table 139. Zhejiang Xianju Pharmaceutical Urinary Tract Infection (UTI) Product

Table 140. Zhejiang Xianju Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 141. Zhejiang Xianju Pharmaceutical Recent Development

Table 142. Sichuan Guorui Pharmaceutical Company Details

Table 143. Sichuan Guorui Pharmaceutical Business Overview

Table 144. Sichuan Guorui Pharmaceutical Urinary Tract Infection (UTI) Product

Table 145. Sichuan Guorui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 146. Sichuan Guorui Pharmaceutical Recent Development

Table 147. Hengrui Pharmaceutical Company Details

Table 148. Hengrui Pharmaceutical Business Overview

Table 149. Hengrui Pharmaceutical Urinary Tract Infection (UTI) Product

Table 150. Hengrui Pharmaceutical Revenue in Urinary Tract Infection (UTI) Business (2020-2025) & (US$ Million)

Table 151. Hengrui Pharmaceutical Recent Development

Table 152. Research Programs/Design for This Report

Table 153. Key Data Information from Secondary Sources

Table 154. Key Data Information from Primary Sources

Table 155. Authors List of This Report

List of Figures

Figure 1. Urinary Tract Infection (UTI) Picture

Figure 2. Global Urinary Tract Infection (UTI) Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Urinary Tract Infection (UTI) Market Share by Type: 2024 VS 2031

Figure 4. By Site of Infection Features

Figure 5. By Clinical Symptoms Features

Figure 6. By Presence of Urinary Tract Abnormalities Features

Figure 7. Global Urinary Tract Infection (UTI) Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Urinary Tract Infection (UTI) Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Clinic Case Studies

Figure 11. Self-administered Case Studies

Figure 12. Others Case Studies

Figure 13. Urinary Tract Infection (UTI) Report Years Considered

Figure 14. Global Urinary Tract Infection (UTI) Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Urinary Tract Infection (UTI) Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Urinary Tract Infection (UTI) Market Share by Region: 2024 VS 2031

Figure 17. Global Urinary Tract Infection (UTI) Market Share by Players in 2024

Figure 18. Global Top Urinary Tract Infection (UTI) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Tract Infection (UTI) as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Urinary Tract Infection (UTI) Revenue in 2024

Figure 20. North America Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Urinary Tract Infection (UTI) Market Share by Country (2020-2031)

Figure 22. United States Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Urinary Tract Infection (UTI) Market Share by Country (2020-2031)

Figure 26. Germany Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Urinary Tract Infection (UTI) Market Share by Region (2020-2031)

Figure 34. China Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Urinary Tract Infection (UTI) Market Share by Country (2020-2031)

Figure 42. Mexico Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Urinary Tract Infection (UTI) Market Share by Country (2020-2031)

Figure 46. Turkey Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Urinary Tract Infection (UTI) Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Novartis AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 50. GlaxoSmithKline Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 51. Dr. Reddy’s Laboratories Ltd., Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 53. Roche Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 54. AstraZeneca, Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 55. Cipla Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 56. Johnson & Johnson Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 57. Bayer AG Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 59. Boehringer Ingelheim Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 60. Sanofi Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 61. Lily Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 62. Abbott Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 63. JinShuiBao Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 64. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 65. Sinopharm Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 66. Borui Medicine Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 67. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 68. Sichuan Guorui Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 69. Hengrui Pharmaceutical Revenue Growth Rate in Urinary Tract Infection (UTI) Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)